After Intellia Therapeutics paused a pair of phase 3 trials for its CRISPR therapy in response to a liver safety signal, the ...
A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...
Health Secretary Robert F. Kennedy Jr. called the treatment 'a powerful glimpse into the future of personalized medicine' ...
Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by chemist Brian Liau and his collaborators at Harvard offers an ...
Yale researchers have created a new method for simulating “aging-like” chromosome errors in mouse eggs to better understand ...
Ozempic, MRI machines and flat screen televisions all emerged out of fundamental research decades earlier — the very types of ...
BEVs carry diverse molecular cargo that offers non-invasive biomarkers for early diagnosis and monitoring of PCOS and ...
Mutations in ZRSR2 have been linked with disease progression in patients with JAK2 V617R – driven myeloproliferative neoplasms (MPNs), but a new report suggests that loss of ZRSR2 alone is not ...
What scientific knowledge is and is not presumed in legal reasoning, and what are the differences between what is and what is ...
5don MSN
Discovery of viral entry routes and decoy molecules could block yellow fever and encephalitis
Researchers at Washington University School of Medicine in St. Louis have identified central routes that two deadly viruses take to invade human cells and have designed decoy molecules that block the ...
Groups of districts already working on escaping the factory model applied for grant money to work on innovative high school options.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback